BioPharma

16 July, 2026 | Thursday | Expert Insight

From Capacity to Capability: The New Race to Lead ASEAN Biomanufacturing

  ASEAN is entering a new phase of biopharmaceutical manufacturing, where simply building more capacity will no longer guarantee competitiveness. As product pipelines become more complex and demand increa...

Lab

17 July, 2026 | Friday | News

Metabolon Expands Microbiome Panel to Screen Over 800 Metabolites

Enhanced panel screens for more than 800 microbiome-associated metabolites, giving researchers a broader view of microbial activity linked to human health, nutrition, disease, and treatment response Metabolon,...

BioTech

08 July, 2026 | Wednesday | Analysis

After the Rush: APAC's mRNA and Vaccine Capacity Hangover

In June 2022,  South Korea had something it had wanted for two years: a COVID-19 vaccine of its own. SKYCovione, developed by SK bioscience with the University of Washington's Institute for Protein Design ...

Contract Services

17 July, 2026 | Friday | News

Merck Invests €25M to Expand BioReliance Testing Capabilities in Europe

• New 2,000-square-meter facility expands Merck’s global testing network with commercial drug substance and drug product release testing and GMP-compliant stability studies• Strategic loca...

Consumer Health

16 July, 2026 | Thursday | Analysis

Two Chairs, 11,000 Kilometres Apart: The Human Cost of Asia’s Plasma Dependence

REPORTAGE  /  PLASMA SUPPLY THE CHAIR The chair reclines. That is the first thing you notice, walking into a plasma centre in a strip mall on the east side of a mid-sized American city, next to a ...

Medtech

10 July, 2026 | Friday | News

India's Garware Fulflex Acquires U.S. Medical Manufacturing Facility to Accelerate Global Expansion

Garware Fulflex today announced the successful completion of its acquisition of a 300,000-square-foot, fully automated medical products manufacturing facility in Jacksonville, Texas, marking a major milestone i...

Cell & Gene

08 July, 2026 | Wednesday | News

World's First International Patient Begins Satri-cel Treatment at Jiahui International Cancer Center

Jiahui International Cancer Center (JICC) has welcomed the world's first international patient to begin treatment with Satri-cel, the world's first approved CAR-T therapy for a solid tumor, marking a historic m...


Biopharma APAC Infomercial

Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close